Its over valued. Not enough patients, other indication in P2, HIGHLY premature $22 Price Target.... Sell and laugh all the way to the bank. Even 1Billion is way out of line with only a few thousand , maybe 10K patients who "Might" end up on this Rx. Good luck. No need to reply .
CF pt's who need the Rx...way small group of pt's. maybe 10K patients first year or two if you figure 20% penetration. Other indications in P2. I don't think i know enough to say jump in (INSM). The new price target of $22 seems a bit premature. at any point good luck with that. If i had bought it at ...say $7...I would be dumping it right about now.
He is a liar like all shorts. Probably still licking his wounds from shorting at $7.Now lets see if he is dumb enough to reply after I placed him in the Iggy Box with the other dimwits including BarGayGuy
SO SHORT.. RISK thousands to gain pennies. There is no limit....NO LIMIT to how much you could lose. Much easier to go long and say dirty things about bargayguy and more fun too. He is getting Corn Rolled weekly.